Annual SGA
$62.48 M
+$31.08 M+98.98%
December 31, 2024
Summary
- As of March 12, 2025, DYN annual SGA is $62.48 million, with the most recent change of +$31.08 million (+98.98%) on December 31, 2024.
- During the last 3 years, DYN annual SGA has risen by +$33.76 million (+117.57%).
- DYN annual SGA is now at all-time high.
Performance
DYN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$15.30 M
+$2.44 M+19.01%
December 31, 2024
Summary
- As of March 12, 2025, DYN quarterly SGA is $15.30 million, with the most recent change of +$2.44 million (+19.01%) on December 31, 2024.
- Over the past year, DYN quarterly SGA has increased by +$5.60 million (+57.78%).
- DYN quarterly SGA is now -37.84% below its all-time high of $24.62 million, reached on March 31, 2024.
Performance
DYN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.27 B
-$317.42 M-10.74%
December 31, 2024
Summary
- As of March 12, 2025, DYN TTM SGA is -$3.27 billion, with the most recent change of -$317.42 million (-10.74%) on December 31, 2024.
- Over the past year, DYN TTM SGA has dropped by -$3.32 billion (-6619.61%).
- DYN TTM SGA is now -16469.10% below its all-time high of -$19.75 million.
Performance
DYN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DYN Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +99.0% | +57.8% | -6619.6% |
3 y3 years | +117.6% | +101.2% | -10000.0% |
5 y5 years | +2142.6% | +101.2% | -10000.0% |
DYN Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +121.5% | -37.8% | +151.2% | -408.5% | at low |
5 y | 5-year | at high | +2142.6% | -37.8% | +1163.7% | <-9999.0% | at low |
alltime | all time | at high | >+9999.0% | -37.8% | +2265.2% | <-9999.0% | at low |
Dyne Therapeutics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $62.48 M(+99.0%) | $15.30 M(+19.0%) | $62.48 M(+11.5%) |
Sep 2024 | - | $12.86 M(+32.6%) | $56.02 M(+11.6%) |
Jun 2024 | - | $9.70 M(-60.6%) | $50.18 M(+4.4%) |
Mar 2024 | - | $24.62 M(+178.4%) | $48.09 M(+53.2%) |
Dec 2023 | $31.40 M(+11.3%) | $8.84 M(+25.9%) | $31.40 M(+6.4%) |
Sep 2023 | - | $7.02 M(-7.7%) | $29.51 M(-2.0%) |
Jun 2023 | - | $7.61 M(-4.1%) | $30.10 M(+5.3%) |
Mar 2023 | - | $7.93 M(+14.0%) | $28.58 M(+1.4%) |
Dec 2022 | $28.20 M | $6.96 M(-8.6%) | $28.20 M(-8.7%) |
Sep 2022 | - | $7.61 M(+24.9%) | $30.91 M(+4.6%) |
Jun 2022 | - | $6.09 M(-19.3%) | $29.55 M(-0.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $7.55 M(-21.9%) | $29.75 M(+3.6%) |
Dec 2021 | $28.72 M(+113.6%) | $9.66 M(+54.4%) | $28.72 M(+12.4%) |
Sep 2021 | - | $6.26 M(-0.6%) | $25.56 M(+10.4%) |
Jun 2021 | - | $6.29 M(-3.3%) | $23.14 M(+27.2%) |
Mar 2021 | - | $6.51 M(+0.1%) | $18.19 M(+35.3%) |
Dec 2020 | $13.45 M(+382.7%) | $6.50 M(+69.3%) | $13.45 M(+64.9%) |
Sep 2020 | - | $3.84 M(+186.4%) | $8.16 M(+64.4%) |
Jun 2020 | - | $1.34 M(-24.0%) | $4.96 M(+37.0%) |
Mar 2020 | - | $1.76 M(+45.7%) | $3.62 M(+94.9%) |
Dec 2019 | $2.79 M(+438.9%) | $1.21 M(+87.2%) | $1.86 M(+187.2%) |
Sep 2019 | - | $647.00 K | $647.00 K |
Dec 2018 | $517.00 K | - | - |
FAQ
- What is Dyne Therapeutics annual SGA?
- What is the all time high annual SGA for Dyne Therapeutics?
- What is Dyne Therapeutics annual SGA year-on-year change?
- What is Dyne Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly SGA year-on-year change?
- What is Dyne Therapeutics TTM SGA?
- What is the all time high TTM SGA for Dyne Therapeutics?
- What is Dyne Therapeutics TTM SGA year-on-year change?
What is Dyne Therapeutics annual SGA?
The current annual SGA of DYN is $62.48 M
What is the all time high annual SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high annual SGA is $62.48 M
What is Dyne Therapeutics annual SGA year-on-year change?
Over the past year, DYN annual SGA has changed by +$31.08 M (+98.98%)
What is Dyne Therapeutics quarterly SGA?
The current quarterly SGA of DYN is $15.30 M
What is the all time high quarterly SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly SGA is $24.62 M
What is Dyne Therapeutics quarterly SGA year-on-year change?
Over the past year, DYN quarterly SGA has changed by +$5.60 M (+57.78%)
What is Dyne Therapeutics TTM SGA?
The current TTM SGA of DYN is -$3.27 B
What is the all time high TTM SGA for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM SGA is -$19.75 M
What is Dyne Therapeutics TTM SGA year-on-year change?
Over the past year, DYN TTM SGA has changed by -$3.32 B (-6619.61%)